Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of Directors
Senior management
Our history
Research and development
Technology platform
Therapeutic areas
Pipeline
Scientific papers and presentations
Partnering
Our approach
Our partnerships
Investors
Financial reports and presentations
Share information
Analyst coverage
Major shareholders
Financial calendar
Corporate governance
Corporate governance statements
Dividend policy
Annual general meeting
Articles of association
Safe harbour statement
Whistleblower policy
Risk management
Investor relations policy
ESG
Email alerts
Newsroom
Press Releases
Image library
Glossary
Email alerts
Careers
Life at Nykode
Meet us
Open positions
Search
Investors
Financial reports and presentations
Latest company presentation (PDF)
Newest first
Oldest first
Presentations
Financial reports
Webcasts
Search
Reset
11/05/2022
Capital Markets Day in Oslo on May 12, 2022 – webcast
09/05/2022
Nykode Therapeutics – Interim results from Phase 2 trial with VB10.16 in combination with atezolizumab in advanced cervical cancer – presentation
09/05/2022
Nykode Therapeutics – Interim results from Phase 2 trial with VB10.16 in combination with atezolizumab in advanced cervical cancer – webcast
20/04/2022
Kempen Life Sciences Conference – April 20, 2021
01/04/2022
Nykode Therapeutics – full year 2021 financial results and corporate presentation
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer
